Public Profile

Piramal Pharma Limited

Piramal Pharma Limited, a prominent player in the global pharmaceutical industry, is headquartered in India and operates extensively across key regions, including North America, Europe, and Asia. Founded in 1988, the company has achieved significant milestones, establishing itself as a leader in both contract development and manufacturing, as well as in the formulation of complex generics. Piramal Pharma's core offerings include a diverse range of pharmaceutical products and services, with a strong emphasis on innovative drug delivery systems and advanced therapies. Their commitment to quality and sustainability sets them apart in a competitive market. With a robust portfolio and a focus on research and development, Piramal Pharma Limited continues to enhance its market position, contributing to healthcare solutions worldwide.

DitchCarbon Score

How does Piramal Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

43

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Piramal Pharma Limited's score of 43 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

77%

Let us know if this data was useful to you

Piramal Pharma Limited's reported carbon emissions

In 2024, Piramal Pharma Limited reported total greenhouse gas emissions of approximately 56230000 kg CO2e for Scope 1, about 79415000 kg CO2e for Scope 2, and around 499659000 kg CO2e for Scope 3 emissions. This reflects a commitment to transparency in their carbon footprint across all scopes of emissions. Piramal Pharma has set ambitious climate targets, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2022 as the base year. Additionally, they are committed to a 25% reduction in absolute Scope 3 emissions, which include significant categories such as purchased goods and services, fuel and energy-related activities, and upstream transportation and distribution, also by FY2030. These targets align with industry standards and demonstrate Piramal Pharma's commitment to addressing climate change and reducing their environmental impact. The company has not yet committed to a net-zero target but is actively working towards substantial emissions reductions in the near term.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
41,396,000
00,000,000
00,000,000
00,000,000
Scope 2
74,243,220
00,000,000
00,000,000
00,000,000
Scope 3
477,407,000
-
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Piramal Pharma Limited's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Piramal Pharma Limited is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Piramal Pharma Limited is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Abbott

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 7 days ago

Cipla

IN
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Dabur

IN
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 9 days ago

Divis Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Laurus Labs

IN
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Syngene

IN
Health and social work services (85)
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers